SCHEMBL992810

SCHEMBL992810

NS(=O)(=O)CCNC1CCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.40
CA2 P00918 3/20 0.40
TAAR1 Q96RJ0 1/20 0.35
CA12 O43570 3/20 0.33
CA7 P43166 3/20 0.33
CA14 Q9ULX7 3/20 0.33
CXCR4 P61073 3/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ANPEP P15144 2/20 0.32
ERAP2 Q6P179 2/20 0.32
RAD52 P43351 1/20 0.32
NFE2L2 Q16236 1/20 0.31
DPP4 P27487 2/20 0.31
FAP Q12884 1/20 0.31
DPP7 Q9UHL4 1/20 0.31
CXCL12 P48061 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15083704 0.94 CA1 (0.48) CA1CA2TAAR1CA12CA7
SCHEMBL3903305 0.83 CA1 (0.42) CA1CA2CA12CA7CA14
SCHEMBL3904237 0.82 CA1 (0.45) CA1CA2CA12CA7CA14
SCHEMBL18747653 0.78 S1PR4 (0.36) CA1CA2TAAR1CA12CA7
SCHEMBL30675060 0.78 ACHE (0.35) CA1CA2TAAR1CA12CA7
SCHEMBL18747676 0.74 KDM4E (0.39) CA1CA2TAAR1CA12CA7
SCHEMBL18747649 0.72 KDM4E (0.42) CA1CA2TAAR1CA12CA7
SCHEMBL18747702 0.72 KDM4E (0.42) CA1CA2TAAR1CA12CA7
SCHEMBL161732 0.72 KDM4E (0.42) CA1CA2TAAR1CA12CA7
SCHEMBL18747671 0.72 KDM4E (0.42) CA1CA2TAAR1CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454257-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES Abbott Laboratories (US) 2012-05-23 EP disclosed
WO-2011008915-A1 PYRROLOPYRIDINE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2011-01-20 WO disclosed